Evidence map›Paper›PMID 36106121›Full record

ArticleFrontiers in oncology2022

Robust treatment planning in scanned carbon-ion radiotherapy for pancreatic cancer: Clinical verification using in-room computed tomography images.

Yohsuke Kusano, Hiroyuki Katoh, Shinichi Minohara, Hajime Fujii, Yuya Miyasaka, Yoshiki Takayama, Koh Imura, Terufumi Kusunoki, Shin Miyakawa, Tadashi Kamada and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Carbon ion radiotherapy optimization techniques for pancreatic cancer: accounting for the effect of bowel gas variation.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Yohsuke KusanoSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Hiroyuki KatohDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Shinichi MinoharaSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Hajime FujiiAccelerator Engineering Corporation, Kanagawa Office, Chiba, Japan.
Yuya MiyasakaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Yoshiki TakayamaSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Koh ImuraSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Terufumi KusunokiSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Shin MiyakawaSection of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Japan.
Tadashi KamadaDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Itsuko SerizawaDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Yosuke TakakusagiDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Nobutaka MizoguchiDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Keisuke TsuchidaDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Daisaku YoshidaDepartment of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kanagawa Prefectural Hospital Organization · JPKanagawa Cancer CenterYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Carbon-ion beam (C-beam) has a sharp dose distribution called the Bragg peak. Carbon-ion radiation therapy, such as stereotactic body radiotherapy in photon radiotherapy, can be completed in a short period by concentrating the radiation dose on the tumor while minimizing the dose to organs at-risk. However, the stopping position of C-beam is sensitive to density variations along the beam path and such variations can lower the tumor dose as well as cause the delivery of an unexpectedly high dose to the organs at risk. We evaluated the clinical efficacy of a robust planning technique considering gastrointestinal gas (G-gas) to deliver accurate radiation doses in carbon-ion radiotherapy for pancreatic cancer. Materials and methods: We focused on the computed tomography (CT) value replacement method. Replacement signifies the overwriting of CT values in the CT images. The most effective replacement method for robust treatment planning was determined by verifying the effects of the three replacement patterns. We selected 10 consecutive patients. Pattern 1 replaces the CT value of the G-gas contours with the value of the region without G-gas (P1). This condition indicates a no-gas state. Pattern 2 replaces each gastrointestinal contour using the mean CT value of each contour (P2). The effect of G-gas was included in the replacement value. Pattern 3 indicates no replacement (P3). We analyzed variations in the target coverage (TC) and homogeneity index (HI) from the initial plan using in-room CT images. We then performed correlation analysis on the variations in G-gas, TC, and HI to evaluate the robustness against G-gas. Results: Analysis of variations in TC and HI revealed a significant difference between P1 and P3 and between P2 and P3. Although no statistically significant difference was observed between P1 and P2, variations, including the median, tended to be fewer in P2. The correlation analyses for G-gas, TC, and HI showed that P2 was less likely to be affected by G-gas. Conclusion: For a treatment plan that is robust to G-gas, P2 mean replacement method should be used. This method does not necessitate any particular software or equipment, and is convenient to implement in clinical practice.

Indexed as

carbon-ion radiotherapygastrointestinal gasin-room CTpancreatic cancerreplacementrobust treatment planscanning beam

Identifiers

PMID36106121
PMCPMC9465304
OpenAlexW4293426217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.